1. Home
  2. VRAX vs TXMD Comparison

VRAX vs TXMD Comparison

Compare VRAX & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited

HOLD

Current Price

$0.17

Market Cap

1.7M

Sector

Health Care

ML Signal

HOLD

Logo TherapeuticsMD Inc.

TXMD

TherapeuticsMD Inc.

HOLD

Current Price

$2.24

Market Cap

25.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRAX
TXMD
Founded
2013
2008
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7M
25.9M
IPO Year
2021
2012

Fundamental Metrics

Financial Performance
Metric
VRAX
TXMD
Price
$0.17
$2.24
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$1.00
N/A
AVG Volume (30 Days)
161.6K
19.6K
Earning Date
03-10-2026
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
80.61
EPS
N/A
N/A
Revenue
N/A
$1,761,000.00
Revenue This Year
$217,274.83
$427.09
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$90.64
Revenue Growth
N/A
35.25
52 Week Low
$0.18
$0.83
52 Week High
$1.35
$2.95

Technical Indicators

Market Signals
Indicator
VRAX
TXMD
Relative Strength Index (RSI) 36.65 48.54
Support Level N/A $2.10
Resistance Level $0.25 $2.35
Average True Range (ATR) 0.02 0.11
MACD 0.00 -0.01
Stochastic Oscillator 0.46 57.14

Price Performance

Historical Comparison
VRAX
TXMD

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

Share on Social Networks: